EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small vessel ischemic stroke patients who receive short-term or intermittent monitoring (i.e., Holter monitors and 30-day external monitors) may not be optimally managed for recurrent stroke prevention versus those who received continuous monitoring with insertable cardiac monitors.
News | Implantable Cardiac Monitor (ICM)
New Simulation Data From the STROKE AF Study Shows Insertable Cardiac Monitors Detect 4 Times More AF than Intermittent Monitoring

April 29, 2022 – Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small ...

Home April 29, 2022
Home
Vektor Medical has announced positive results from its “Vektor vMap Clinical Validation Study” evaluating the accuracy of cardiac mapping with vMap.
News | EP Mapping and Imaging Systems
Vektor Medical to Present Positive Results from vMap Clinical Validation Study

April 29, 2022 – Vektor Medical has announced positive results from its “Vektor vMap Clinical Validation Study” ...

Home April 29, 2022
Home
CathVision, a medical technology company developing innovative electrophysiology solutions designed to guide and enhance cardiac ablation therapy through the acquisition of low-noise, high-fidelity electrograms, announced the completion of patient enrollment in the CathVision ECGenius System clinical evaluation study at the University of Vermont Medical Center.
News | EP Lab
CathVision Announces Completion of Patient Enrollment at First U.S. Clinical Trial Evaluating High-Fidelity, Low-Noise EP Recording Technology

April 27, 2022 – CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home April 27, 2022
Home
The U.S. Preventive Services Task Force (USPSTF) has released its final recommendations on low-dose aspirin therapy for the primary prevention of cardiovascular disease in adults
News | Stroke
New USPSTF Guidance: Continue to Take Low-Dose Aspirin if you have a History of Heart Attack, AFib, Stroke or Vascular Stenting

April 27, 2022 – The U.S. Preventive Services Task Force (USPSTF) has released its final recommendations on low-dose asp ...

Home April 27, 2022
Home
Researchers at the National Cerebral and Cardiovascular Center in Japan found that patients aged ≥75 years with non-valvular atrial fibrillation (NVAF) and previous stroke/transient ischemic attack (TIA) more commonly had subsequent ischemic and hemorrhagic events than those without previous stroke/TIA in the prospective, multicenter, observational All Nippon AF In the Elderly (ANAFIE) Registry.
News | Stroke
Elderly NVAF Patients with Previous Stroke Need to be More Cautious for Stroke Recurrence

April 25, 2022 – Researchers at the National Cerebral and Cardiovascular Center in Japan found that patients aged ≥75 ...

Home April 25, 2022
Home
Smart watch heart monitor
News | Wearables
Smartwatch App Found to Accurately Detect Atrial Fibrillation

April 14, 2022 – Atrial fibrillation (AFib) was confirmed in nearly 94% of people who were initially identified to have ...

Home April 14, 2022
Home
Biotres device
News | ECG
Biotricity to Launch Commercial Sales of Cardiac Monitoring Device Biotres

April 12, 2022 – Biotricity, a medical diagnostic and consumer healthcare technology company, will officially launch the ...

Home April 12, 2022
Home
News | EP Lab
Late-breaking Data at ACC.22 with Over 1 Million Patients Demonstrates a Major Gap in Guideline Adherence Resulting in Higher Mortality for Patients with Infected CIEDs

Royal Philips, a global leader in health technology, announced late-breaking results of a large-scale, real-world ...

Home April 12, 2022
Home
atrial fibrillation
News | Atrial Fibrillation
Zio by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF

April 12, 2022 –  iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement ...

Home April 12, 2022
Home
Fitbit received clearance from the U.S. Food and Drug Administration for our new PPG (photoplethysmography) algorithm to identify atrial fibrillation (AFib). The algorithm will power our new Irregular Heart Rhythm Notifications feature on Fitbit.
News | Wearables
New Fitbit Feature Makes AFib Detection More Accessible

April 12, 2022 — Fitbit received clearance from the U.S. Food and Drug Administration for its new PPG (photoplethysmogra ...

Home April 12, 2022
Home
Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of patients with non-ST segment elevation myocardial infarction (NSTEMI).
News | Implantable Cardiac Monitor (ICM)
Insertable Cardiac Monitors (ICM) and Remote Monitoring May Improve Outcomes for Post-Myocardial Infarction Patients, Study Demonstrates

April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of ...

Home April 06, 2022
Home
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients in the U.S. with slow heart rhythms.
News | Pacemakers
Abbott Receives FDA Approval for Aveir VR Leadless Pacemaker System

April 5, 2022 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Aveir single-chamber ...

Home April 05, 2022
Home
Stereotaxis’ Genesis Robotic Magnetic Navigation (RMN) system
News | Robotic Systems
National Institute of Cardiology Becomes First Hospital in Poland to Establish Advanced Robotic Program to Treat Heart Rhythm Disorders

April 1, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac ...

Home March 31, 2022
Home
The poster titled “Short term prediction of Atrial Fibrillation from ambulatory ECG using deep learning” presents results of a clinical study demonstrating that Cardiologs’ AI algorithm can predict the short-term risk of atrial fibrillation (AFib) based on single-lead Ambulatory electrocardiograms (ECGs) that show normal sinus rhythm.
News | Atrial Fibrillation
Cardiologs Announces Poster Presentation at ACC 2022

April 1, 2022 — Cardiologs announced a poster presentation at the 2022 American College of Cardiology (ACC) meeting in ...

Home April 01, 2022
Home
The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held April 3-5 at the Bella Center in Copenhagen, Denmark and online. Explore the scientific program.
News | ESC
EHRA 2022: Cutting Edge Science in Heart Rhythm Disorders

March 31, 2022 — The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held ...

Home March 31, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now